Skip to main content
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.040
+0.010 (0.33%)
At close: Mar 6, 2026, 4:00 PM EST
3.027
-0.013 (-0.44%)
After-hours: Mar 6, 2026, 7:14 PM EST

C4 Therapeutics Revenue

In the year 2025, C4 Therapeutics had annual revenue of $35.95M with 1.02% growth. C4 Therapeutics had revenue of $11.02M in the quarter ending December 31, 2025, with 112.79% growth.

Revenue (ttm)
$35.95M
Revenue Growth
+1.02%
P/S Ratio
8.25
Revenue / Employee
$326,791
Employees
110
Market Cap
296.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202535.95M363.00K1.02%
Dec 31, 202435.58M14.83M71.44%
Dec 31, 202320.76M-10.34M-33.25%
Dec 31, 202231.10M-14.69M-32.08%
Dec 31, 202145.79M12.59M37.93%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CCCC News

More News